Determinants of the growth hormone nadir during oral glucose tolerance test in adults - commentary
Affiliation
Endocrinology, Christie Hospital, Manchester, M20 4BX,Issue Date
2019
Metadata
Show full item recordCitation
Trainer PJ, Monaghan P. Determinants of the growth hormone nadir during oral glucose tolerance test in adults - commentary. Eur J Endocrinol. 2019 Sep 1.Journal
European Journal of EndocrinologyDOI
10.1530/EJE-19-0661PubMed ID
31480015Additional Links
https://dx.doi.org/10.1530/EJE-19-0661Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1530/EJE-19-0661
Scopus Count
Collections
Related articles
- The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
- Authors: Karavitaki N, Fernandez A, Fazal-Sanderson V, Wass JA
- Issue date: 2009 Dec
- Acromegaly: are new tests needed?
- Authors: Spada A
- Issue date: 2003 Feb
- Pitfalls in the diagnosis of acromegaly.
- Authors: Pokrajac-Simeunovic A, Trainer PJ
- Issue date: 2004
- Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.
- Authors: Freda PU, Reyes CM, Nuruzzaman AT, Sundeen RE, Bruce JN
- Issue date: 2003
- Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
- Authors: Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD
- Issue date: 2004 Feb